173 related articles for article (PubMed ID: 15297961)
1. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.
Bell DA; Longacre TA; Prat J; Kohn EC; Soslow RA; Ellenson LH; Malpica A; Stoler MH; Kurman RJ
Hum Pathol; 2004 Aug; 35(8):934-48. PubMed ID: 15297961
[TBL] [Abstract][Full Text] [Related]
2. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
[TBL] [Abstract][Full Text] [Related]
3. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
4. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
5. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
6. Ovarian serous borderline tumors: the citadel defended.
Kurman RJ; Seidman JD
Hum Pathol; 2000 Nov; 31(11):1439-42. PubMed ID: 11112224
[No Abstract] [Full Text] [Related]
7. Current challenges and opportunities for research on borderline ovarian tumors.
Sherman ME; Berman J; Birrer MJ; Cho KR; Ellenson LH; Gorstein F; Seidman JD
Hum Pathol; 2004 Aug; 35(8):961-70. PubMed ID: 15297963
[TBL] [Abstract][Full Text] [Related]
8. Low-grade serous tumors of ovary.
Bell DA
Int J Gynecol Pathol; 2014 Jul; 33(4):348-56. PubMed ID: 24901394
[TBL] [Abstract][Full Text] [Related]
9. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.
Seidman JD; Soslow RA; Vang R; Berman JJ; Stoler MH; Sherman ME; Oliva E; Kajdacsy-Balla A; Berman DM; Copeland LJ
Hum Pathol; 2004 Aug; 35(8):918-33. PubMed ID: 15297960
[TBL] [Abstract][Full Text] [Related]
10. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.
Longacre TA; McKenney JK; Tazelaar HD; Kempson RL; Hendrickson MR
Am J Surg Pathol; 2005 Jun; 29(6):707-23. PubMed ID: 15897738
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.
Smith Sehdev AE; Sehdev PS; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):725-36. PubMed ID: 12766576
[TBL] [Abstract][Full Text] [Related]
12. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 May; 30(5):614-24. PubMed ID: 16699316
[TBL] [Abstract][Full Text] [Related]
13. Serous borderline tumours of the ovary.
Kurman RJ; Seidman JD; Shih IM
Histopathology; 2005 Sep; 47(3):310-5. PubMed ID: 16115232
[TBL] [Abstract][Full Text] [Related]
14. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.
Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ
Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973
[TBL] [Abstract][Full Text] [Related]
15. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S; Friedrich K; Redline R; Avril S
Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
[TBL] [Abstract][Full Text] [Related]
17. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
18. Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.
Imamura H; Ohishi Y; Aman M; Shida K; Shinozaki T; Yasutake N; Sonoda K; Kato K; Oda Y
Hum Pathol; 2015 Oct; 46(10):1455-63. PubMed ID: 26232113
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
20. [New concepts of pathology in serious borderline tumor in ovarian neoplasm].
Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):182-3. PubMed ID: 10682490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
